rs369160589

Variant summary

Our verdict is Pathogenic.
+11 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 11 classification points (ACMG Germline Pathogenicity v2019). PS3PM2_SupportingPP3_ModeratePP5_Strong

The NM_019109.5(ALG1):c.1187+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000218 (AC=352) in the gnomAD database across 1,611,132 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000264. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (no review stars). ClinVar reports functional evidence for this variant: "SCV000746579: cDNA experiments performed on a research basis demonstrated that the paternally inherited variant (c.1187+3A>G) is damaging." and additional evidence is available in ClinVar.

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

ALG1
NM_019109.5 splice_region, intron

Scores

3
Splicing: ADA: 0.9997
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:14U:1O:1

Conservation

PhyloP100: 3.37

Publications

3 publications found
Variant links:
Genes affected
ALG1 (HGNC:18294): (ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase) The enzyme encoded by this gene catalyzes the first mannosylation step in the biosynthesis of lipid-linked oligosaccharides. This gene is mutated in congenital disorder of glycosylation type Ik. [provided by RefSeq, Dec 2008]
ALG1 Gene-Disease associations (from GenCC):
  • ALG1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P, Orphanet, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_019109.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 11 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000746579: cDNA experiments performed on a research basis demonstrated that the paternally inherited variant (c.1187+3A>G) is damaging.; SCV000827732: Studies have shown that this variant results in retention of intron 11 of the ALG1 gene, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 28554332).; SCV001164452: cDNA analysis by the NIH Undiagnosed Diseases Network demonstrated this variant has a damaging effect (Variation ID: 224118). PMID: 26931382; SCV003921901: Quantitative PCR from a patient's blood RNA showed the variant led to increased retention of intron 11, which is predicted to result in a premature stop codon and nonsense-mediated decay (NMD) of RNA (PMID: 28554332).; SCV000491480: Non-canonical splice site variant demonstrated to result in loss of function (Bowling et al., 2017); SCV001653091: "In vitro qPCR analysis demonstrates a retention of exon 11 and a stop gain after the addition of 84 nucleotides, consistent with pathogenicity." PMID:28554332; SCV003922320: RT-PCR analysis performed on affected tissue showed evidence of intron retention before exon 12, leading to a premature stop codon after addition of 84bp (PMID: 28554332).; SCV004108945: RT-PCR analysis indicated this variant leads to retention of intron 11, resulting in addition of 84 nucleotides (28 codons) and a stop gain (Bowling et al. 2017. PubMed ID: 28554332; González-Domínguez et al. 2021. PubMed ID: 34567092).
PM2Absent/extremely low in population databases
Rare in gnomAD for AR/unknown gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.000264 — borderline rare for AR gene (threshold 0.001) — PM2 supporting.
PP3Computational evidence supports damaging effect
Splicing predictors (SpliceAI/dbscSNV) support splicing impact — moderate computational evidence (PP3); Splicing verdict: pathogenic (Moderate).; Germline computational verdict: not pathogenic.
PP5Reputable source reports pathogenic
ClinVar 0-star pathogenic — supporting (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 0 star(s). ClinVar submissions strongly and reliably favor pathogenicity (13/14 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_019109.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ALG1 NM_019109.5
MANE Select
HGVSc / HGVSpc.1187+3A>G
Exon rankIntron 11 of 12
splice_regionintron
Prot: NP_061982.3
ALG1 NM_001438123.1
HGVSc / HGVSpc.1148+3A>G
Exon rankIntron 10 of 11
splice_regionintron
Prot: NP_001425052.1UniProt: A0A804HJL6
ALG1 NM_001330504.2
HGVSc / HGVSpc.854+3A>G
Exon rankIntron 11 of 12
splice_regionintron
Prot: NP_001317433.1UniProt: Q9BT22-2

Ensembl Transcripts

ALG1 ENST00000262374.10
TSL:1MANE Select
HGVSc / HGVSpc.1187+3A>G
Exon rankIntron 11 of 12
splice_regionintron
Prot: ENSP00000262374.5UniProt: Q9BT22-1
ALG1 ENST00000588623.5
TSL:1
HGVSc / HGVSpc.854+3A>G
Exon rankIntron 12 of 13
splice_regionintron
Prot: ENSP00000468118.1UniProt: Q9BT22-2
ALG1 ENST00000591822.5
TSL:1
HGVSc / HGVSpn.*1088+3A>G
Exon rankIntron 11 of 12
splice_regionintron
Prot: ENSP00000467865.1UniProt: K7EQK1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.000118
AC:18
Hom:0
AN:152218
Cov:33
GnomAD2 exomes
AF: 0.000100
AC:25
AN:249520
GnomAD4 exome
AF: 0.000229
AC:334
Hom:0
AN:1458914
Cov:34
GnomAD4 genome
AF: 0.000118
AC:18
Hom:0
AN:152218
Cov:33
TOPMed (Bravo)
AF: 0.000117
AC:31
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000730
AC:4
Hom:0
AN:54788
Local & regional cohorts 2 sources
ESP6500 (Exome Variant Server)
AF: 0.000247
AC:3
AN:12132
UK10K
AF: 0.000264
AC:2
AN:7562
Showing 8 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.000141 428420 0.000173 528844
SCHEMA
(Schizophrenia)
0.0000519 6115618 0.0000663 12180992
Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
8
-
-
ALG1-congenital disorder of glycosylation (9)
2
-
-
Congenital disorder of glycosylation (2)
1
-
-
ALG1-related disorder (1)
1
-
-
Congenital disorder of glycosylation type I (1)
1
-
-
Encephalopathy (1)
-
1
-
Fetal anomalies with a likely genetic cause (1)
1
-
-
not provided (1)

Computational Scores

AlphaGenome AVI
Pathogenic25
BayesDel_noAF
Benign-0.32
CADD
Benign23
DANN
Benign0.96
GPN-Star LLR
N/A-5.6
GPN-Star score
N/A5.6
Mutation Taster
N/A6/94disease causing (ClinVar)
PhyloP100
Benign3.4
Showing 8 of 8 scores

Splicing Scores

dbscSNV1_ADA
Pathogenic1.0
dbscSNV1_RF
Pathogenic0.96
DS_DL_spliceai
Pathogenic0.66
Position offset: -3
Pangolin (max)
Pathogenic0.55
Pangolin loss
Pathogenic0.55
Position offset: -3
SpliceAI score (max)
Pathogenic0.66
Details are displayed if max score is > 0.2
Showing 6 of 6 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.